RARA CRAFT DATABASE for FDA Medical Devices

Biolinq Shine, the Glucose Monitor That Shows a Color Instead of a Number, Goes OTC a Year After Its De Novo

日本語版

Biolinq Shine is worn on the inside of the forearm. Seven microelectrodes on the underside of the wearable sit in the upper dermis and measure glucose in interstitial fluid continuously. Instead of putting a number on a watch or a phone, the wearable itself shows a color: blue for 70 to 180 mg/dL, yellow for 181 to 400 mg/dL, red below 70 mg/dL. It is designed to be placed where the user can see it.

On September 18, 2026, the device received 510(k) clearance (K262599). The predicate is the same product, granted through De Novo on September 23, 2025 (DEN240080) as a prescription device. The 510(k) changes only the wording of the indication and the labeling; the sensor, software and hardware are unchanged. The submission that made it an over-the-counter product was received on July 27 and decided 53 days later.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles